Author:
Pulkki Jutta,Aaltonen Mari,Raitanen Jani,Rissanen Pekka,Jylhä Marja,Forma Leena
Abstract
AbstractWhile it is known that those who are living their last years are frequent users of social and health services, research about medicines at the end of life is scarce. We examined whether the proportions of purchasers and the types of prescription medicines purchased during a 2-year period differed between community-dwelling old people who died (decedents) in 2002, 2006 or 2011 and old people who lived at least 2 years longer (survivors) in Finland. We also examined how those differences changed over time. The study population was identified from nationwide registers and consisted of 174,097 community-dwelling people who were 70 years of age or older. Of these, 81,893 were decedents and 92,204 survivors. Data on purchases of medicines were gathered from the Finnish prescription database. Along with descriptive analyses, binary logistic regression analysis was used to find the association between decedent status and the purchase of medicines in general and different categories of medicines in particular. Almost all community-dwelling decedents and survivors purchased medicines at least once during the 2-year period. Over time, the proportion of purchasers increased in both groups but especially among survivors, thereby reducing the differences between the groups. However, the probability of purchasing medicines in general and different categories of medicine in particular remained significantly higher for decedents than for survivors after adjustments. This study shows that purchases of medication are concentrated at the end of life, as is the use of social and health services. However, the differences between decedents and survivors diminish over time.
Funder
Academy of Finland
Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospital
Social Insurance Institution
NordForsk
Publisher
Springer Science and Business Media LLC
Subject
Geriatrics and Gerontology,Health(social science)
Reference40 articles.
1. Aaltonen M, Pulkki J, Forma L, Raitanen J, Rissanen P, Jylhä M (2016) The cost and reimbursements of drugs for Alzheimer disease multiplied in the last years of life. Lääkärilehti 71(43):2723–2729
2. Barat I, Andreasen F, Damsgaard M (2000) The consumption of medicines by 75-year-old individuals living in their own homes. Eur J Clin Pharmacol 56:501–509
3. Bell S, Klaukka T, Ahonen J, Hartikainen S (2009) National utilization of transdermal fentanyl among community-dwelling older people in Finland. Am J Geriatr Pharmacother 17:355–361
4. Blomgren J, Einiö E (2015) The deinstitutionalisation of old age care: its association with other long-term care services and outpatient medical expenses in 2000–2013. Yhteiskuntapolitiikka 80(4):334–348
5. Crimmins EM, Beltrán-Sánchez H (2011) Mortality and morbidity trends: is there compression of morbidity? J Gerontol Ser B 1(1):75–86
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献